Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 6 (4), e009986

Prenatal Exposure to Cannabis and Maternal and Child Health Outcomes: A Systematic Review and Meta-Analysis

Affiliations
Review

Prenatal Exposure to Cannabis and Maternal and Child Health Outcomes: A Systematic Review and Meta-Analysis

J K L Gunn et al. BMJ Open.

Abstract

Objective: To assess the effects of use of cannabis during pregnancy on maternal and fetal outcomes.

Data sources: 7 electronic databases were searched from inception to 1 April 2014. Studies that investigated the effects of use of cannabis during pregnancy on maternal and fetal outcomes were included.

Study selection: Case-control studies, cross-sectional and cohort studies were included.

Data extraction and synthesis: Data synthesis was undertaken via systematic review and meta-analysis of available evidence. All review stages were conducted independently by 2 reviewers.

Main outcomes and measures: Maternal, fetal and neonatal outcomes up to 6 weeks postpartum after exposure to cannabis. Meta-analyses were conducted on variables that had 3 or more studies that measured an outcome in a consistent manner. Outcomes for which meta-analyses were conducted included: anaemia, birth weight, low birth weight, neonatal length, placement in the neonatal intensive care unit, gestational age, head circumference and preterm birth.

Results: 24 studies were included in the review. Results of the meta-analysis demonstrated that women who used cannabis during pregnancy had an increase in the odds of anaemia (pooled OR (pOR)=1.36: 95% CI 1.10 to 1.69) compared with women who did not use cannabis during pregnancy. Infants exposed to cannabis in utero had a decrease in birth weight (low birth weight pOR=1.77: 95% CI 1.04 to 3.01; pooled mean difference (pMD) for birth weight=109.42 g: 38.72 to 180.12) compared with infants whose mothers did not use cannabis during pregnancy. Infants exposed to cannabis in utero were also more likely to need placement in the neonatal intensive care unit compared with infants whose mothers did not use cannabis during pregnancy (pOR=2.02: 1.27 to 3.21).

Conclusions and relevance: Use of cannabis during pregnancy may increase adverse outcomes for women and their neonates. As use of cannabis gains social acceptance, pregnant women and their medical providers could benefit from health education on potential adverse effects of use of cannabis during pregnancy.

Keywords: PREVENTIVE MEDICINE; PUBLIC HEALTH.

Figures

Figure 1
Figure 1
Flow of studies through the review process. ICU, intensive care unit; NICU, neonatal intensive care unit.

Similar articles

See all similar articles

Cited by 54 PubMed Central articles

See all "Cited by" articles

References

    1. WHO. Management of substance abuse: Cannabis. 7 July 2015. http://www.who.int/substance_abuse/facts/cannabis/en/
    1. Crime, U.N.O.o.D.a. World drug report. 2014. http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf
    1. Degenhardt L, Whiteford H, Hall WD. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev 2014;33:4–12. 10.1111/dar.12088 - DOI - PubMed
    1. Board, I.N.C, U.N.V.I. Centre, and Austria. International Narcotics Control Board: 2013 Annual Report, 2013.
    1. English D, Hulse GK, Milne E et al. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997;92:1553–60. 10.1111/j.1360-0443.1997.tb02875.x - DOI - PubMed
Feedback